课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
7983570
负责人:
James R. Heath
金额:
$11.61万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-03 至 2015-07-31
关键词:
AddressAnimal ModelAnimalsAreaAtlasesBackBaltimoreBasic ScienceBelgiumBiochemistryBioinformaticsBiologicalBiological AssayBiological MarkersBiological ModelsBiologyBloodBlood ProteinsBrainBrain NeoplasmsCCNE1 geneCancer BiologyCancer CenterCancer ModelCancer PatientCancer cell lineCell Culture TechniquesCell LineCellsChemicalsChinClinicClinicalClinical SciencesClinical ServicesClinical TrialsCollaborationsCollectionCommitCommunitiesComplementComplexComprehensive Cancer CenterComputational TechniqueCore FacilityDNADataData SetDevelopmentDevicesDiagnosisDiagnosticDiscipline of Nuclear MedicineDoctor of PhilosophyEngineeringEnrollmentEnvironmentEnzymesEpigenetic ProcessEvaluationFosteringFoundationsFresh TissueFundingGene MutationGene Transduction AgentGenerationsGenesGeneticGenomicsGlioblastomaGliomaGrantGynecologic OncologyGynecologic Oncology GroupHeterogeneityHome environmentHouse miceHumanHuman ResourcesImageImaging technologyImmune systemImmunologic MonitoringImmunologistImmunologyImmunotherapyIn VitroIndividualInstitutesIonsJonsson Comprehensive Cancer Center of University of California Los AngelesKineticsLabelLaboratoriesLettersLuxembourgMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryManuscriptsMass Spectrum AnalysisMeasurementMechanicsMedicalMelanoma CellMentorsMetabolicMetabolismMethodologyMicrofluidicsMissionModelingMolecularMolecular AnalysisMolecular BiologyMolecular MedicineMonitorMusNanotechnologyOperating RoomsOperative Surgical ProceduresOrganPathologistPathologyPathway AnalysisPathway interactionsPatientsPharmacodynamicsPharmacologyPhysiciansPopulation HeterogeneityPositron-Emission TomographyPrincipal InvestigatorProcessProdrugsPropertyProteinsProteomicsRNA InterferenceRadiochemistryRegenerative MedicineReproduction sporesResearchResearch PersonnelResistanceResourcesSamplingScientistScreening procedureSerumSignal TransductionSmall Interfering RNASolidSpecific qualifier valueStem Cell ResearchSumSupport SystemSystemSystems BiologyT-LymphocyteTechniquesTechnologyTherapeuticTissue BankingTissue BanksTissue HarvestingTissue MicroarrayTissue SampleTissuesTouch sensationTracerTraining ProgramsTranscriptTransgenic MiceTransgenic OrganismsTranslatingTranslationsTumor Stem CellsTumorigenicityUnited States National Institutes of HealthUrsidae FamilyValidationVisionWorkXenograft Modelanticancer researchbasecancer cellcancer diagnosiscancer genomecancer immunotherapycancer stem cellcancer therapycareer developmentchemical synthesisclinically relevantcommercializationcostdesignexperienceexperimental analysisflexibilitygene therapygene therapy clinical trialhuman subjectimage reconstructionimaging probeimprovedin vivoin vivo Cellular and Molecular Imaging Centersin vivo Modelinnovationinstrumentationmedical specialtiesmeetingsmelanomaminimally invasivemolecular imagingmouse modelnanonanofluidicnanoparticleneuro-oncologynovelnovel therapeuticsoncologyoptical imagingpharmacokinetic modelphysical sciencepre-clinicalprogramsprototyperesistance mechanismsmall hairpin RNAstem cell biologysuccesstargeted deliverytechnology developmenttissue culturetooltumortumor growth

项目摘要

项目成果

James R. Heath的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The NSBCC administrative Core is described. The NSBCC is Directed by Jim Heath and co-Directed by Mike Phelps & Leroy Hood. Heath bears overall responsibility for the center, and specific responsibility for the technology development components. Dr. Hood bears specific responsibility for oversight of the biology (and systems biology) project components, and Dr. Phelps oversees the clinical translation of NSBCC projects. Each of the NSBCC leaders has extensive expertise in technology development, clinical translation, and technology commercialization. The NSBCC Leaders are guided by an Internal Review Council comprised of the Project Principal Investigators, and by an External Advisory Board. Descriptions of that guidance are provided. Rationale for how the scientific and personnel composition of the individual projects provide for a culture in which the sum of the components is greater than the parts is given - including a proven vision for accelerating the process of technology innovation to clinical demonstration. Significant partnerships with NCI funded programs, including the Jonsson Comprehensive Cancer Center, are described. Leverage from foundation funded programs and institutes, such as the Broad Institute for Regenerative Medicine, are discussed. Additional funding from foundation and other resources provides significant leverage for the NSBCC projects, and significantly accelerates our pathway into the clinic. Additional partnerships with for-profit companies (Sofie Biosciences, Integrated Diagnostics, and Momentum Biosciences) are described. Examples of how these partnerships are already leading to the commercial development of NSBCC technologies (from existing CCNE funding) are provided.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    10526102
  • 项目类别:
  • 资助金额:
    $24.66万
  • 财政年份:
    2022
  • 负责人:
    James R. Heath
  • 依托单位:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
  • 批准号:
    10708901
  • 项目类别:
  • 资助金额:
    $254.9万
  • 财政年份:
    2022
  • 负责人:
    James R. Heath
  • 依托单位:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
  • 批准号:
    10907268
  • 项目类别:
  • 资助金额:
    $14.72万
  • 财政年份:
    2022
  • 负责人:
    James R. Heath
  • 依托单位:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
  • 批准号:
    10526101
  • 项目类别:
  • 资助金额:
    $270.26万
  • 财政年份:
    2022
  • 负责人:
    James R. Heath
  • 依托单位:
海外基金